Short description
SyntheticGestalt develops machine learning models for drug discovery and software for facilitating and automating research.
Description
SyntheticGestalt creates tools and methods for applied machine learning-based drug discovery that are aimed at streamlining and automating research in the life sciences sector. The company's synthetic biology simulation models can accurately predict the outcomes of various amino acid arrangements without having to perform time-consuming experimental steps, helping pharmaceutical companies by automating and accelerating the drug development process. Preclinical candidates are chemical compounds discovered through research that have the potential to become new drugs for the treatment of a particular disease.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
London, England, United Kingdom, Europe
Founded on
September 18, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccessforu, Noaccess, Noaccess, Uh Ohhhh
Sign in for full access
Founders
Atsuhiro Hagiwara, Koki Shimada, Kotaro Kamiya